Akums Drugs and Pharmaceuticals Limited (AKUMS) Share Analysis
NSE · Healthcare · Healthcare
Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹784.00, market capitalisation ₹12,335 Cr, P/E 40.4, ROE 8.45%.
Get the AI verdict on AKUMS: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
AKUMS price and valuation
- Share price
- ₹784.00
- Market cap
- ₹12,335 Cr
- P/E ratio
- 40.4
- P/B ratio
- 3.72
- EPS
- ₹18.53
- Book value per share
- ₹211.00
- Dividend yield
- 0.13%
AKUMS profitability and growth
- ROE
- 8.45%
- ROCE
- 14.9%
- Debt to equity
- 0.06
- Revenue growth (3 yr)
- 6%
- Revenue growth (5 yr)
- 10%
- Profit growth (3 yr)
- 29%
- Profit growth (5 yr)
- 16%
AKUMS 52-week range
- 52-week high
- ₹796.55
- 52-week low
- ₹409.30
- Face value
- ₹2.00
AKUMS shareholding pattern
- Promoters
- 75.26%
- FIIs
- 1.91%
- DIIs
- 13.44%
- Public
- 6.67%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.